Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant.

Kidney international reports·2026
Same author

Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study.

BMJ open·2026
Same author

Associations of serum uric acid levels with podocyte injury and kidney histopathologic lesions.

Journal of nephrology·2026
Same author

Development and Validation of the Risk of Exacerbation in Severe Asthma (RESA) Model.

The journal of allergy and clinical immunology. In practice·2026
Same author

The Association of Urine Albumin to Protein Ratio With Kidney Disease Progression.

Kidney medicine·2026
Same author

Cell enlargement drives aging-associated proteome remodeling and shortens replicative lifespan.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 18, 2026

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

Angiogenic dysfunction in molar pregnancy.

David Kanter1, Marshall D Lindheimer, Eileen Wang

  • 1Department of Obstetrics and Gynecology, The Pritzker School of Medicine, University of Chicago, Chicago, IL, USA.

American Journal of Obstetrics and Gynecology
|November 20, 2009
PubMed
Summary
This summary is machine-generated.

Molar pregnancies show higher levels of antiangiogenic proteins, specifically fms-like tyrosine kinase receptor 1 (Flt1) and its soluble form (sFlt1). This suggests overproduction contributes to early preeclampsia in molar pregnancies.

More Related Videos

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
06:55

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus

Published on: December 5, 2015

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

Related Experiment Videos

Last Updated: Jun 18, 2026

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
06:55

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus

Published on: December 5, 2015

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Pathology

Background:

  • Molar pregnancy is linked to early-onset preeclampsia.
  • Antiangiogenic factors are implicated in preeclampsia pathogenesis.

Purpose of the Study:

  • To investigate whether molar placentas overproduce antiangiogenic proteins compared to normal placentas.
  • To test the hypothesis that increased antiangiogenic factors contribute to preeclampsia in molar pregnancy.

Main Methods:

  • Retrospective case-control study comparing 19 molar placentas with 16 normal controls.
  • Immunohistochemical analysis using antisera for fms-like tyrosine kinase receptor 1 (Flt1)/soluble Flt1 (sFlt1) and CD31.
  • Stain intensity was semiquantitatively graded.

Main Results:

  • Molar placentas exhibited significantly higher Flt1/sFlt1 staining intensity compared to normal controls (P < .0001).

Conclusions:

  • A significant difference in Flt1/sFlt1 immunostaining was observed between molar and normal placentas.
  • Findings support the hypothesis that trophoblast overproduction of antiangiogenic proteins, like Flt1/sFlt1, contributes to the preeclampsia phenotype in molar pregnancy.